The role of complex genomic alterations in neuroblastoma risk estimation

Specific genomic alterations, such as loss of the chromosomal region 11q or amplification of the oncogene MYCN, are well established markers of poor outcome in neuroblastoma. The advent of microarray-based comparative genomic hybridization (array-CGH) has enabled the analysis of pangenomic alteratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Matthias, Berthold, Frank
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887075/
https://www.ncbi.nlm.nih.gov/pubmed/20497596
http://dx.doi.org/10.1186/gm152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887075/
https://www.ncbi.nlm.nih.gov/pubmed/20497596
http://dx.doi.org/10.1186/gm152

Ejemplares similares